Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Petroni

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2004
Assessment of the toxicities of systemic low-dose interleukin-2 administered in conjunction with a melanoma peptide vaccineElizabeth M H Woodson, Kimberly A Chianese-Bullock, Catherine J Wiernasz, et al.
The Journal of Surgical Research|January 22, 2023
Evaluation of Preoperative and Intraoperative Mobile Gamma Camera Imaging in Sentinel Lymph Node Biopsy for Melanoma Independent of Preoperative LymphoscintigraphyJoshua M Judge, Kosta Popovic, Gina R Petroni, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2021
Characterization and comparison of innate and adaptive immune responses at vaccine sites in melanoma vaccine clinical trialsMarit M Melssen, Karlyn E Pollack, Max O Meneveau, et al.
The American Journal of Pathology|July 8, 1999
Origin of microsatellite instability in gastric cancerK C Halling, J Harper, C A Moskaluk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group BBruce A Peterson, Gina R Petroni, Glauco Frizzera, et al.
Journal for Immunotherapy of Cancer|May 26, 2021
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonistMax O Meneveau, Gina R Petroni, Elise P Salerno, et al.
Hematology/Oncology and Stem Cell Therapy|January 12, 2023
Prophylactic Pretransplant Ganciclovir to Reduce Cytomegalovirus Infection After Hematopoietic Stem Cell TransplantationDaniel R Reed, Gina R Petroni, Melissa West, et al.
Clinical Trials (London, England)|September 1, 2011
Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trialsAnneke T Schroen, Gina R Petroni, Hongkun Wang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 26, 2015
PGC-1β regulates HER2-overexpressing breast cancer cells proliferation by metabolic and redox pathwaysVanessa Jacob Victorino, W A Barroso, A K M Assunção, et al.
Journal for Immunotherapy of Cancer|June 29, 2019
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patientsMarit M Melssen, Gina R Petroni, Kimberly A Chianese-Bullock, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2004
Assessment of the toxicities of systemic low-dose interleukin-2 administered in conjunction with a melanoma peptide vaccineElizabeth M H Woodson, Kimberly A Chianese-Bullock, Catherine J Wiernasz, et al.
The Journal of Surgical Research|January 22, 2023
Evaluation of Preoperative and Intraoperative Mobile Gamma Camera Imaging in Sentinel Lymph Node Biopsy for Melanoma Independent of Preoperative LymphoscintigraphyJoshua M Judge, Kosta Popovic, Gina R Petroni, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2021
Characterization and comparison of innate and adaptive immune responses at vaccine sites in melanoma vaccine clinical trialsMarit M Melssen, Karlyn E Pollack, Max O Meneveau, et al.
The American Journal of Pathology|July 8, 1999
Origin of microsatellite instability in gastric cancerK C Halling, J Harper, C A Moskaluk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group BBruce A Peterson, Gina R Petroni, Glauco Frizzera, et al.
Journal for Immunotherapy of Cancer|May 26, 2021
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonistMax O Meneveau, Gina R Petroni, Elise P Salerno, et al.
Hematology/Oncology and Stem Cell Therapy|January 12, 2023
Prophylactic Pretransplant Ganciclovir to Reduce Cytomegalovirus Infection After Hematopoietic Stem Cell TransplantationDaniel R Reed, Gina R Petroni, Melissa West, et al.
Clinical Trials (London, England)|September 1, 2011
Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trialsAnneke T Schroen, Gina R Petroni, Hongkun Wang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 26, 2015
PGC-1β regulates HER2-overexpressing breast cancer cells proliferation by metabolic and redox pathwaysVanessa Jacob Victorino, W A Barroso, A K M Assunção, et al.
Journal for Immunotherapy of Cancer|June 29, 2019
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patientsMarit M Melssen, Gina R Petroni, Kimberly A Chianese-Bullock, et al.
Pageof 13